The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(pyridin-2-yl)-N-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide ID: ALA4562029
PubChem CID: 118211419
Max Phase: Preclinical
Molecular Formula: C27H25F3N6O3S
Molecular Weight: 570.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)cn1
Standard InChI: InChI=1S/C27H25F3N6O3S/c28-27(29,30)39-21-9-5-7-19(14-21)15-23(37)33-22-12-11-18(17-32-22)6-1-2-10-25-35-36-26(40-25)34-24(38)16-20-8-3-4-13-31-20/h3-5,7-9,11-14,17H,1-2,6,10,15-16H2,(H,32,33,37)(H,34,36,38)
Standard InChI Key: MWQHDHACYVMQLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
4.3322 -16.3025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3310 -17.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0391 -17.5310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7487 -17.1216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7459 -16.2989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0373 -15.8937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6230 -17.5301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9156 -17.1209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2721 -16.7458 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7802 -16.2749 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1173 -17.4209 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.4571 -17.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1641 -17.1194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8725 -17.5268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1629 -16.3022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5796 -17.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2866 -17.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9932 -17.1169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9924 -16.2989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2790 -15.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5754 -16.3029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6989 -15.8882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4078 -16.2948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1143 -15.8841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8232 -16.2907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5297 -15.8800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2777 -16.2073 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8227 -15.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4120 -14.8919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6132 -15.0642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6357 -15.6815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1141 -15.0190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9270 -15.1021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7795 -14.2734 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4055 -14.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2166 -14.5261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6948 -13.8645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3603 -13.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5429 -13.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0683 -13.6997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 26 2 0
28 31 1 0
31 32 1 0
32 33 1 0
32 34 2 0
33 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 570.60Molecular Weight (Monoisotopic): 570.1661AlogP: 5.15#Rotatable Bonds: 12Polar Surface Area: 118.99Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.94CX Basic pKa: 4.67CX LogP: 5.84CX LogD: 5.31Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.23Np Likeness Score: -1.89
References 1. Zimmermann SC, Duvall B, Tsukamoto T.. (2018) Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase., 62 (1): [PMID:29969024 ] [10.1021/acs.jmedchem.8b00327 ] 2. Li L, Meng Y, Li Z, Dai W, Xu X, Bi X, Bian J.. (2019) Discovery and development of small molecule modulators targeting glutamine metabolism., 163 [PMID:30522056 ] [10.1016/j.ejmech.2018.11.066 ]